A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score
Fig 1
Distribution of patient samples when risk scores calculated with Gail model plus PRS compared to the Streamlined models plus PRS.
Log-transformed values of the five-year risk distributions and the t-test results for the risk estimates obtained by the Gail model plus PRS versus the Streamlined model plus PRS. The t-test indicates that there is no difference in mean values between the Streamlined model plus PRS and Gail model plus PRS (p = 0.8441).